查詢結果分析
相關文獻
- The Survey of the Life Span of Vascular Access for Patients with Diabetes on Hemodialysis
- 探討南臺灣血液透析患者血管通路存活率之危險因子
- 血液透析病患動靜脈瘻管使用年限與PTA治療之分析
- 照顧一位長期血液透析病人--血管通路多次重建的護理經驗
- Pseudoaneurysm of Common Carotid Artery: A Complication from Cannulation of Jugular Vein Hemodialysis Catheter
- Percutaneous Transluminal Angioplasty for Dysfunctioned Vascular Access in Chronic Hemodialysis Patients
- Directional Atherectomy for Vascular Access Salvage in Chronic Hemodialysis Patients
- 概觀血液透析之血管通路
- 血管通路功能不良的病理機轉
- 血管通路栓塞的危險因子與預防
頁籤選單縮合
題名 | The Survey of the Life Span of Vascular Access for Patients with Diabetes on Hemodialysis=糖尿病血液透析患者血管通路之使用年限調查 |
---|---|
作 者 | 陳建文; 賴麗英; 蕭淑惠; 李仁慈; 楊恩智; 蕭善良; | 書刊名 | Medical Journal of South Taiwan |
卷期 | 6:2 2010.12[民99.12] |
頁次 | 頁76-80 |
分類號 | 415.816 |
關鍵詞 | 血液透析; 自體動靜脈瘻管; 人工植入瘻管; 血管通路; 經皮穿腔血管成形術; Hemodialysis; AV fistula; AV graft; Thrombosis; Precutaneous transluminal angioplasty; PTA; |
語文 | 英文(English) |
中文摘要 | 目的:尿毒症患者血管通路主要是提供血液透析時有足夠的血流量,有良好的血管通路才能提供足夠的清除率,避免因透析不足而引發尿毒症的各種合併症。末期腎衰竭常見的原因中糖尿病佔約40%,而糖尿病會造成動脈粥狀硬化,同樣為瘻管阻塞或狹窄之原因。方法:利用HOPE資料庫分析某院362位常規血液透析病患的瘻管使用年限,調查糖尿病患者之透析瘻管存活天數及阻塞率是否有異於非糖尿病。結果:自體瘻管使用年限,在非糖尿病患者明顯高於糖尿病(1,787±1,051 vs. 1,473±853天; P=0.007)。而在人工瘻管使用年限,非糖尿病患者與糖尿病患者並無差異(1,410±929 vs. 1,366±984天; P=0.873),且根據本研究顯示糖尿病患者的人工瘻管與自體瘻管使用年限相當(1,366±984天vs. 1,473±853天)無統計學上差異。結論:因人工瘻管的成形度佳,對於糖尿病患者或當本身血管條件不佳,是否應優先考慮人工瘻管,值得進一步研究。 |
英文摘要 | Objective: Patients with end stage renal disease (ESRD) on hemodialysis must maintain good vascular access function for treatment so sufficient blood flow is provided and sufficient clearance is achieved, otherwise inadequate dialysis will lead to a variety of complications caused by uremia. Diabetes accounts for about 40% of the common causes of ESRD, and it causes arteriosclerosis, which causes thrombosis or stenosis of vascular access.Methods: We analyzed the life span of AV fistula of 362 regular hemodialysis patients in our hospital with the HOPE database and investigated whether there are any differences of the life span and thrombotic rate of vascular access between diabetic and non-diabetic patients.Results: The results showed that the life span of arteriovenous fistula (AV fistula) of non-diabetic patients is significantly longer than that of the diabetic patients (1,787 days ± 1051 days to 1,473 days ± 853 days; P = 0.007). There are no differences of the life span of AV graft between non-diabetic and diabetic patients (1,410 days ± 929 days to 1,366 days ± 984 days; P=0.873). Moreover, the study showed that there are no significant statistical differences between the life span of AV graft and AV fistula of patients with diabetes (1,366 days ± 984 days to 1,473 days ±853 days).Conclusions: However, AV graft forms adequate vascular diameter more easily. Therefore, for patients with diabetes or poor vascular condition, whether to give priority to AV fistula or not needs further investigation. |
本系統之摘要資訊系依該期刊論文摘要之資訊為主。